← Leaderboards
Moua Yang
Beth Israel Deaconess Medical Center
$826,968
Attributed
$826,968
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$826,968 · 2
By mechanism
R00$498,000 · 1
K99$328,968 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Kun Ping Lu$22,478,971
- Bruce Furie$39,376,853
- Robert C Flaumenhaft$19,499,862
- Jeffrey Zwicker$3,964,427
- Gerburg M Wulf$4,301,499
Others in their field
Other Rising Stars on “Antioxidants”
- Ricardo Valladares · Siolta Therapeutics, Inc.$2,921,132
- Paul Tang · University Of Michigan At Ann Arbor$2,648,134
- David Jackson · Ceria Therapeutics, Inc.$2,340,033
- Claudia Martinez · University Of Miami School Of Medicine$2,302,500
- Andrew Abell · University Of Tx Md Anderson Can Ctr$1,947,017
- Luigi Brunetti · Rutgers Biomedical And Health Sciences$1,703,215
Research focus
AntioxidantsAdhesionsBiologyBlood PlateletsCarbonCell AdhesionCell-Cell AdhesionCellsCharacteristicsClinical ResearchComplementCysteineDisease ModelDisulfidesElectronsElectron TransportEndothelial CellsEnvironmentEventExtracellularFetal HemoglobinFlavonoidsGlutamineHemoglobin
Grant awards (4)
Oxidative Cysteine Modification by Thiol Isomerases in Sickle Cell Disease$249,000
R00 · FY2025 · HL · contact PI
Oxidative Cysteine Modification by Thiol Isomerases in Sickle Cell Disease$249,000
R00 · FY2024 · HL · contact PI
Oxidative Cysteine Modification by Thiol Isomerases in Sickle Cell Disease$164,484
K99 · FY2023 · HL · contact PI
Oxidative Cysteine Modification by Thiol Isomerases in Sickle Cell Disease$164,484
K99 · FY2022 · HL · contact PI